 - Biochemically progressive disease defined by two serial PSA measurements obtained 1 week apart during ongoing optimal androgen-deprivation therapy e.g., orchiectomy, luteinizing hormone-releasing hormone LHRH agonist, or another equivalent hormonal agent 